Discover

BIVI
BioVie Inc.
1.32
11 x 1.25
8 x 1.41
bid
ask
+
0.03
2.16%
09:25 AM
timesize
Ytd13.61%
1y-83.91%
1.30
day range
1.31
1.06
52 week range
8.40
Open1.31Prev Close1.29Low1.30High1.31Mkt Cap9.73M
Vol1.40KAvg Vol164.03KEPS-2.69P/E-0.48Forward P/E-0.49
Beta0.57Short Ratio0.15Inst. Own9.99%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-1150-d Avg1.68200-d Avg1.521yr Est5.00

BIVI News

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses

Why Eva Live Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Eva Live Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Eva Live gained 16.4% in pre-market trading after signing a letter of intent to acquire Airbeam Wire

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Agenus (NASDAQ:AGEN) shares increased by 95.8% to $6.56 during Monday's regular session

Did BioVie Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
Did BioVie Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob

BioVie Inc. (BIVI) Discusses Clinical Updates on Bezisterim and BIV201 for Parkinson's, Alzheimer's, and Ascites Transcript
seekingalpha.com
BioVie Inc. (BIVI) Discusses Clinical Updates on Bezisterim and BIV201 for Parkinson's, Alzheimer's,

BioVie Inc. (BIVI) Discusses Clinical Updates on Bezisterim and BIV201 for Parkinson's, Alzheimer's,

BioVie: Long COVID trial fully enrolled – ICYMI
proactiveinvestors.com
BioVie: Long COVID trial fully enrolled – ICYMI

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) earlier this week announced that its Phase 2 long COVID trial

BioVie: Long COVID trial fully enrolled – ICYMI
proactiveinvestors.com
BioVie: Long COVID trial fully enrolled – ICYMI

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) earlier this week announced that its Phase 2 long COVID trial

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Join BioVie's Exclusive Live Investor Webinar and Q and A Session on June 2
globenewswire.com
Join BioVie's Exclusive Live Investor Webinar and Q and A Session on June 2

CARSON CITY, Nev., May 27, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Com

BioVie to highlight neuro and liver disease programs in June 2 investor webinar
proactiveinvestors.com
BioVie to highlight neuro and liver disease programs in June 2 investor webinar

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) will host an investor webinar on June 2 at 4:15 p.m. ET featu

BioVie completes enrollment in Phase 2 Long COVID trial
proactiveinvestors.com
BioVie completes enrollment in Phase 2 Long COVID trial

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) said on Tuesday it has completed enrollment in its ADDRESS-LC

BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
globenewswire.com
BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurolog

-Topline Data Release Targeted Late Summer 2026- CARSON CITY, Nev., May 26, 2026 (GLOBE NEWSWIRE) --

BioVie completes final patient visit in Parkinson's drug trial
proactiveinvestors.com
BioVie completes final patient visit in Parkinson's drug trial

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) has completed the last patient evaluation visit in its SUNRIS

BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson's Disease
globenewswire.com
BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson's Disease

Last Patient Evaluation Visit Completed with Topline Data Release Targeted Q3-2026 Last Patient Eval

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

BioVie Inc. (BIVI) Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkinson's Disease Pathology Transcript
seekingalpha.com
BioVie Inc. (BIVI) Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkin

BioVie Inc. (BIVI) Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkin

BioVie CEO shares insights into long COVID trial - ICYMI
proactiveinvestors.com
BioVie CEO shares insights into long COVID trial - ICYMI

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) earlier this week outlined progress in its clinical program t

BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026
globenewswire.com
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Par

CARSON CITY, Nev., April 27, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “C

Why United Rentals Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why United Rentals Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

United Rentals (URI) stock rose in pre-market trading after reporting better-than-expected earnings

BioVie abstract on Parkinson's drug accepted for neurology conference
proactiveinvestors.com
BioVie abstract on Parkinson's drug accepted for neurology conference

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) said on Tuesday an abstract from its mid-stage study of exper

BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
globenewswire.com
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual

CARSON CITY, Nev., April 14, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “C

United, American Airlines possible merger discussed at White House meeting: report
proactiveinvestors.com
United, American Airlines possible merger discussed at White House meeting: report

United Airlines Holdings Inc (NASDAQ:UAL, XETRA:UAL1) and American Airlines Group Inc (NASDAQ:AAL, X

Conagra Brands shares slide as CEO Connolly ousted
proactiveinvestors.com
Conagra Brands shares slide as CEO Connolly ousted

Shares of Conagra Brands Inc (NYSE:CAG) were down more than 5.6% on Monday after the packaged food c

Deutsche Bank cuts RS Group to hold as industrial recovery outlook clouds
proactiveinvestors.com
Deutsche Bank cuts RS Group to hold as industrial recovery outlook clouds

Shares in RS Group (LSE: RS1), the industrial electronics and maintenance products distributor, fell

Shell and BP shares lifted as oil rebounds on breakdown of US-Iran peace talks
proactiveinvestors.com
Shell and BP shares lifted as oil rebounds on breakdown of US-Iran peace talks

Shell PLC (LSE:SHEL, NYSE:SHEL) and BP PLC (LSE:BP.) shares moved higher at the start of the week, o

BioVie CEO explains Bezisterim Parkinson's trial results - ICYMI
proactiveinvestors.com
BioVie CEO explains Bezisterim Parkinson's trial results - ICYMI

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) earlier this week outlined its evolving approach to Parkinson

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  Monday's session saw 84 companies set new 52-week lows.

benzinga.com
77 Biggest Movers From Yesterday

Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday af